| Pages | |
|---|---|
| TrustInformation | |
| Report of theTrustees | 2-6 |
| Independent Auditor's Report to theTrustees | 7-9 |
| Statement of Financial Activities | 10 |
| Balance Sheet | 11 |
| Notes to the Financial Statements | 12-18 |
| Year | Income | Research Expenditure |
|---|---|---|
| 2023 | 268,423 | 162,322 |
| 2024 | 160,498 | 159,074 |
| 2025 | 281,615 | 118,387 |
| Total | Total | ||||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Funds | Funds | ||||
| Notes | Funds | Funds | 2025 | 2024 | |||
| Incomefrom: | |||||||
| Donations and legacies: | |||||||
| Donations | 155,613 | 116,000 | 271,613 | 147,189 | |||
| Charitable activities: | |||||||
| Fund raising events | 2,615 | 2,615 | 8,062 | ||||
| Other trading activities: | |||||||
| Sale ofprints, cards and sweatshirts | 584 | 584 | 756 | ||||
| Investments | 6,803 | 6,803 | 4,491 | ||||
| Totalincome | 165,615 | 116,000 | 281,615 | 160,498 | |||
| Expenditure on: | |||||||
| Charitable activities | 2 | 95,612 | 74,502 | 170,114 | 225,974 | ||
| Raisingfunds | 3 | 32,586 | 32,586 | 38,162 | |||
| Total expenditure | 128,198 | 74,502 | 202,700 | 264,136 | |||
| Net income/(expenditure) before gains | |||||||
| and losses on investments | 37,417 | 41 ,498 | 78,915 | (103,638) | |||
| Realised gains/(losses) on investments | 3,428 | 3,428 | 5,903 | ||||
| Unrealised profits/(losses) on investments | 2,903 | 2,903 | (583) | ||||
| Net income/expenditure for the year | 43,748 | 41,498 | 85,246 | (98,318) | |||
| Transfers between funds | |||||||
| Netmovement in funds | 43,748 | 41 ,498 | 85,246 | (98,3 18) | |||
| Balances brought forward at I May 2024 | 258,930 | 95,487 | 354,417 | E 452,735 | |||
| Balances carried forward at 30 April 2025 | 11 & 12 | E | 302,678 | E 136,985 | E | 439,663 | E 354,417 |
| Notes | 2025 | 2024 | ||||
|---|---|---|---|---|---|---|
| Fixed Assets | ||||||
| TangibleAssets | 6 | 90 | 330 | |||
| Investments | 7 | 375,015 | 272,710 | |||
| 375,105 | 273,040 | |||||
| Current Assets | ||||||
| Stock | 8 | 2,191 | 2,510 | |||
| Debtors | 9 | 2,934 | 2,514 | |||
| Cash at bank and in hand | 67,757 | 139,191 | ||||
| 72,882 | 144,215 | |||||
| Creditors: amounts falling due within one year | 10 | 8,324 | 62,838 | |||
| Net current | assets | 64,558 | 81,377 | |||
| Net Assets | E | 439,663 | E | 354,417 | ||
| Unrestricted | Funds | |||||
| General fund | 11 | 213,574 | 153,231 | |||
| Designated funds | 11 | 89,104 | 105,699 | |||
| 302,678 | 258,930 | |||||
| RestrictedFunds | 12 | 136,985 | 95,487 | |||
| E | 439,663 | E | 354,417 |
Unrestricted fundsare expendable at the discretion of t |
he trustees in furtherance o | fthe objects | ofthecharity | . |
|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |
| 2) Direct Charitable Expenditure | Funds | Funds | 2025 | 2024 |
| Grants formedical research to institutions | 64,660 | 53,727 | 118,387 | 159,074 |
| Costs ofresearch programme | 25,002 | 20,775 | 45,777 | 59,085 |
| Governance costs (Note4) | 5,950 | 5,950 | 7,815 | |
| €95,612 | E74,502 | El 70,114 | E225,974 |
| 2025 | 2024 | |
|---|---|---|
| University of Newcastle | 34,843 | |
| University ofGlasgow | 10,619 | 43,770 |
| Salisbury NHS FoundationTrust | 12,000 | 32,083 |
| University College London | 18,545 | 44,181 |
| University ofBirmingham | 21,481 | 11,000 |
| University of Bath | 20,899 | 28,040 |
| 118,387 | 159,074 |
| Unrestricted | Unrestricted | Restricted | Total | Total | |||
|---|---|---|---|---|---|---|---|
| 3) Cost ofGenerating Funds | Funds | Funds | 2025 | 2024 | |||
| Promotion and fundraising | 13,303 | 13,303 | 12,583 | ||||
| Cost of prints, cards and sweatshirts | 584 | 584 | 1,579 | ||||
| Overheads and governance costs (Note 4) | 18,699 | 18,699 | 24,000 | ||||
| E | 32,586 | E | 32,586 | E | 38,162 |
| El ,400) and for ot | her services ofEl ,500 (2024: El ,520). | ||
|---|---|---|---|
| 2025 | 2024 | ||
| Direct charitable expenditure | 45,777 | 59,085 | |
| Cost ofgeneratingfunds | 17,606 | 22,725 | |
| Governance costs | - medical research | 5,950 | 7,815 |
| Governance costs | - fundraising | 1,092 | 1,275 |
| 70,426 | 90,900 |
| The Foundation employedan average of2 people during the | year (2024: 3) | ||
|---|---|---|---|
| Staffcosts | 2025 | 2024 | |
| Salaries and wages | 54,344 | 72,347 | |
| Social security costs | 133 | 1,908 | |
| Pension costs | 1,820 | 458 | |
| 56,297 | E | 74,713 |
| Thetotalremuneration paid to key management personnel in th | e yearwas E60,606 (2024 - E65, |
994) | |
|---|---|---|---|
| 6) Tangible Fixed Assets | Office | ||
| Equipment | Total | ||
| Cost | |||
| At I May 2024 | 3,675 | 3,675 | |
| Additions | |||
| Disposals | (1,330) | (1,330) | |
| At 30April 2025 | 2,345 | 2,345 | |
| Depreciation | |||
| At 1 May 2024 | 3,345 | 3,345 | |
| Charge for theyear | 240 | 240 | |
| On Disposals | (1,330) | (1,330) | |
| At 30April 2025 | 2,255 | 2,255 | |
| Net Book Value | |||
| At 30April 2025 | 90 | 90 | |
| At 30 April 2024 | 330 | 330 | |
| 7) Investments | |||
| 2025 | 2024 | ||
| Market value as at 30April 2024 | 272,710 | 449,381 | |
| Additions | 207,824 | 169,273 | |
| Disposals | (113,544) | (328,693) | |
| Revaluation | 2,903 | (2,675) | |
| Increase/(decrease) in cash | 5,122 | (14,576) | |
| Market value as at 30April 2025 | E | 375,015 | E 272,710 |
| Historic cost | E | 372,688 | E 265,299 |
| Investments by market value | 2025 | 2024 | ||
|---|---|---|---|---|
| CharitiesAid UK Equity IncomeUnits Fund B | 9,472 | |||
| Royal Bank ofScotland Deposit account | 3 | |||
| Rathbones Portfolio | 210,716 | 154,032 | ||
| OtherBank Deposits accounts | 164,299 | 109,202 | ||
| E | 375,015 | E | 272,709 | |
| 8) Stock | ||||
| 2025 | 2024 | |||
| Prints | 90 | 152 | ||
| Branded products | 2,017 | 2,244 | ||
| Cards | 84 | 114 | ||
| E | 2,191 | 2,510 | ||
| 9) Debtors | 2025 | 2024 | ||
| Prepayments and accrued income | 2,934 | 2,514 | ||
| E | 2,934 | 2,514 |
| IO) Creditors: amountsfallingdue within one year | ||
|---|---|---|
| 2025 | 2024 | |
| Grants payable | 2,500 | 29,359 |
| Salaries | 1,101 | 2,092 |
| Othercreditors | 243 | 449 |
| Accruals and deferred income | 4,480 | 30,938 |
| 8,324 | 62,838 |
| Balance | Balance | ||||||
|---|---|---|---|---|---|---|---|
| 1 | May 2024 | Income | Expenditure | Transfers | 30 | April 2025 | |
| General fund | El53,231 | 165,615 | (121,867) | 16,595 | €213,574 | ||
| Designated formedical research | €105,699 | (16,595) | E89,104 | ||||
| E | 258,930 | E 165,615 | (E121,867) | E | E | 302,678 |
| 11.1) Unrestricted Funds - Year ended |
30 April 2024 | ||||
|---|---|---|---|---|---|
| Balance | Balance | ||||
| 1 May 2023 | Income | Expenditure | Transfers | 30April 2024 | |
| General fund | 248,834 | 92,498 | (191,561) | 3,460 | E153,231 |
| Designatedfor medical research | E109,159 | (3,460) | El05,699 | ||
| E357,993 | E92,498 | (El 91,561) | 258,930 |
| donations and other inco | me held on trust to be applie | d for specifi | c purposes. | ||||
|---|---|---|---|---|---|---|---|
| Balance | Balance | ||||||
| I | May 2024 | Income | Expenditure | Transfers | 30 | April 2025 | |
| Medical research | €95,487 | 116,000 | (74,502) | E | 136,985 | ||
| 12.1) Restricted Funds | - Year ended30 April 2024 | ||||||
| Balance | Balance | ||||||
| I | May 2023 | Income | Expenditure | Transfers | 30 | April 2024 | |
| Medical research | E94,742 | 68,000 | (67,255) | €95,487 |
| ril 2025 are represented by: | ||||
|---|---|---|---|---|
| Unrestricted | Restricted | |||
| Funds | Funds | Total | ||
| Tangible fixed assets | 90 | 90 | ||
| Fixed asset investments | 238,030 | 136,985 | 375,015 | |
| Net current assets / (liabilities) | 64,558 | 64,558 | ||
| Total net assets | E 302,678 | E 136,985 | E | 439,663 |
| ril 2024 are represented by: | ||||
|---|---|---|---|---|
| Unrestricted | Restricted | |||
| Funds | Funds | Total | ||
| Tangible fixed assets | 330 | 330 | ||
| Fixed asset investments | 177,223 | 95,487 | 272,710 | |
| Net current assets / (liabilities) | 81,377 | 81,377 | ||
| Total net assets | E 258,930 | 95,487 | E | 354,417 |
| Year end | 30 | April | 2026 | 226,484 | |
|---|---|---|---|---|---|
| Year end | 30 | April | 2027 | 87,240 | |
| Year end | 30 | April | 2028 | 32,443 | |
| Year end | 30 | April | 2029 | 10,250 | |
| E | 356,417 |
| 16 ) ComparativeStatement of Financial Act | ivity - Year e |
nde | d30 April | 20 | 24 | ||
|---|---|---|---|---|---|---|---|
| Total | |||||||
| Unrestricted | Restricted | Funds | |||||
| Notes | Funds | Funds | 2024 | ||||
| Incomefrom: | |||||||
| Donations and legacies: | |||||||
| Donations | 79,189 | 68,000 | 147,189 | ||||
| Charitable activities: | |||||||
| Fund raising events | 8,062 | 8,062 | |||||
| Other trading activities: | |||||||
| Sale ofprints, cards and sweatshirts | 756 | 756 | |||||
| Investments | 4,491 | ||||||
| Total income | 92,498 | 68,000 | 160,498 | ||||
| Expenditure on: | |||||||
| Charitable activities | 158,719 | 67,255 | 225,974 | ||||
| Raisingfunds | 38,162 | 38,162 | |||||
| Total expenditure | 196,881 | 67,255 | 264,136 | ||||
| Net income/(expenditure)before gains | |||||||
| and losses on investments | (104,383) | 745 | (103,638) | ||||
| Realised profits/(losses) on investments | 5,903 | 5,903 | |||||
| Unrealised profits/(losses) on investments | (583) | (583) | |||||
| Net income/expenditureför the year | (99,063) | 745 | (98,318) | ||||
| Transfers between funds | |||||||
| Net movement in tUnds | (99,063) | 745 | (98,318) | ||||
| Balances brought forward at I May 2023 | 357,993 | 94,742 | 452,735 | ||||
| Balances carried tönvard at 30 April 2024 | E | 258,930 | E | 95,487 | E | 354,417 |